anonymous
Guest
anonymous
Guest
1Q sales performance is a joke!!! Go out there and SELL!! Y'all call yourselves a sales force?
I saw the numbers as well with the earnings release. Something needs to be done and forget 2nd generation if this management team is still in place. Sorry but results drive sustained employment!!1Q sales performance is a joke!!! Go out there and SELL!! Y'all call yourselves a sales force?
WTF --- VPak US sales down -55% compared to 3q15
3q15@ $242M
1q16@ $125M
We beat the street and Ricky's celebrating all weekend. Good job Rick Keep it up. Keep acquiring more backup for 2022 when Humira sales will trickle down. We love Abbvie and no layoffs coming here.
Vpak sales in US are even down to a year ago, 1Q15 by 9.5%. That's pathetic. It was just starting out a year ago!!
Even Bristol-Myers Squibb beat us in 1q16
1q16 HCV Global Revenues ($B)
Gilead - 4.294
Bristol-Myers Squibb - 0.427
Merck - tbd 5/5/16
Abbvie - 0.414
Johnson& Johnson - 0.032
I hate to say it but this has been the WORST LAUNCH in pharma history!! Ricky went forward with this disaster and the Board must let him go!!!Vpak sales in US are even down to a year ago, 1Q15 by 9.5%. That's pathetic. It was just starting out a year ago!!
Vpak sales in US are even down to a year ago, 1Q15 by 9.5%. That's pathetic. It was just starting out a year ago!!
I hate to say it but this has been the WORST LAUNCH in pharma history!! Ricky went forward with this disaster and the Board must let him go!!!
Ouch...good think Haas got that promotion...well deserved.Even Bristol-Myers Squibb beat us in 1q16
1q16 HCV Global Revenues ($B)
Gilead - 4.294
Bristol-Myers Squibb - 0.427
Merck - tbd 5/5/16
Abbvie - 0.414
Johnson& Johnson - 0.032
Gilead stock is tanking ....Rampant layoffs in ONC and HV at Gilead. Foster City is in a panic mode. CEO Milligan is a corporate thief stealing from Patients, America, Veterans, and Taxpayers. .....The biggest scumbag is Dr. Raymond Schinazi, a VA doctor since 1983, he founded Pharmasset and led the scientific team that discovered sofosbuvir while working at VA on the Taxpayers dime....Sold it all for $400 Million .....Who really owns the hepatitis C cure? Taxpayers or the VA employee who invented it while a full-time VA employee? Don't ever talk about Ricky,at least our hep c is priced reasonably. We had no part in this scam.
Ricky couldn't launch a turd into a toilet.....BWAAA HAAA PLAY ON
Very disappointing results! Abbvie Retirees1q16 HCV Global Status
- Gilead maintained q/q same global market share
- Bristol-Myers Squibb gained 0.5%
- Abbvie VPak lost -1.4%
- New player Merck quickly acquired 1.0%
Vpak sales in US are even down to a year ago, 1Q15 by 9.5%. That's pathetic. It was just starting out a year ago!!